ID   RBSK_ECOLI              Reviewed;         309 AA.
AC   P0A9J6; P05054; Q2M870;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   15-MAR-2017, entry version 104.
DE   RecName: Full=Ribokinase {ECO:0000255|HAMAP-Rule:MF_01987, ECO:0000303|PubMed:3011794};
DE            Short=RK {ECO:0000255|HAMAP-Rule:MF_01987};
DE            EC=2.7.1.15 {ECO:0000255|HAMAP-Rule:MF_01987, ECO:0000269|PubMed:11563694, ECO:0000269|PubMed:3011794};
GN   Name=rbsK {ECO:0000255|HAMAP-Rule:MF_01987,
GN   ECO:0000303|PubMed:3011794}; OrderedLocusNames=b3752, JW3731;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 1-21 AND
RP   297-309, FUNCTION, AND CATALYTIC ACTIVITY.
RC   STRAIN=K12;
RX   PubMed=3011794;
RA   Hope J.N., Bell A.W., Hermodson M.A., Groarke J.M.;
RT   "Ribokinase from Escherichia coli K12. Nucleotide sequence and
RT   overexpression of the rbsK gene and purification of ribokinase.";
RL   J. Biol. Chem. 261:7663-7668(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=7686882; DOI=10.1006/geno.1993.1230;
RA   Burland V.D., Plunkett G. III, Daniels D.L., Blattner F.R.;
RT   "DNA sequence and analysis of 136 kilobases of the Escherichia coli
RT   genome: organizational symmetry around the origin of replication.";
RL   Genomics 16:551-561(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   SUBUNIT.
RC   STRAIN=K12;
RX   PubMed=9385653; DOI=10.1002/pro.5560061124;
RA   Sigrell J.A., Cameron A.D., Jones T.A., Mowbray S.L.;
RT   "Purification, characterization, and crystallization of Escherichia
RT   coli ribokinase.";
RL   Protein Sci. 6:2474-2476(1997).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11563694; DOI=10.1023/A:1011081508171;
RA   Maj M.C., Gupta R.S.;
RT   "The effect of inorganic phosphate on the activity of bacterial
RT   ribokinase.";
RL   J. Protein Chem. 20:139-144(2001).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR,
RP   AND ENZYME REGULATION.
RX   PubMed=16784868; DOI=10.1016/j.bmc.2006.05.057;
RA   Chuvikovsky D.V., Esipov R.S., Skoblov Y.S., Chupova L.A.,
RA   Muravyova T.I., Miroshnikov A.I., Lapinjoki S., Mikhailopulo I.A.;
RT   "Ribokinase from E. coli: expression, purification, and substrate
RT   specificity.";
RL   Bioorg. Med. Chem. 14:6327-6332(2006).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.84 ANGSTROMS) IN COMPLEX WITH AMP-PNP AND
RP   RIBOSE.
RC   STRAIN=K12;
RX   PubMed=9519409; DOI=10.1016/S0969-2126(98)00020-3;
RA   Sigrell J.A., Cameron A.D., Jones T.A., Mowbray S.L.;
RT   "Structure of Escherichia coli ribokinase in complex with ribose and
RT   dinucleotide determined to 1.8-A resolution: insights into a new
RT   family of kinase structures.";
RL   Structure 6:183-193(1998).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) IN COMPLEX WITH ADP; MAGNESIUM
RP   AND RIBOSE.
RX   PubMed=10438599; DOI=10.1006/jmbi.1999.2938;
RA   Sigrell J.A., Cameron A.D., Mowbray S.L.;
RT   "Induced fit on sugar binding activates ribokinase.";
RL   J. Mol. Biol. 290:1009-1018(1999).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.34 ANGSTROMS) IN COMPLEX WITH ATP ANALOG;
RP   CESIUM AND RIBOSE, AND ENZYME REGULATION.
RX   PubMed=11786021; DOI=10.1006/jmbi.2001.5248;
RA   Andersson C.E., Mowbray S.L.;
RT   "Activation of ribokinase by monovalent cations.";
RL   J. Mol. Biol. 315:409-419(2002).
CC   -!- FUNCTION: Catalyzes the phosphorylation of ribose at O-5 in a
CC       reaction requiring ATP and magnesium. The resulting D-ribose-5-
CC       phosphate can then be used either for sythesis of nucleotides,
CC       histidine, and tryptophan, or as a component of the pentose
CC       phosphate pathway. {ECO:0000255|HAMAP-Rule:MF_01987,
CC       ECO:0000269|PubMed:11563694, ECO:0000269|PubMed:3011794}.
CC   -!- CATALYTIC ACTIVITY: ATP + D-ribose = ADP + D-ribose 5-phosphate.
CC       {ECO:0000255|HAMAP-Rule:MF_01987, ECO:0000269|PubMed:11563694,
CC       ECO:0000269|PubMed:16784868, ECO:0000269|PubMed:3011794}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01987,
CC         ECO:0000269|PubMed:16784868, ECO:0000305|PubMed:11786021};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:16784868};
CC       Note=Requires a divalent cation, most likely magnesium in vivo, as
CC       an electrophilic catalyst to aid phosphoryl group transfer. It is
CC       the chelate of the metal and the nucleotide that is the actual
CC       substrate (Probable). Also active with manganase
CC       (PubMed:16784868). {ECO:0000255|HAMAP-Rule:MF_01987,
CC       ECO:0000269|PubMed:16784868, ECO:0000305|PubMed:11786021};
CC   -!- ENZYME REGULATION: Activated by a monovalent cation that binds
CC       near, but not in, the active site (PubMed:11786021). The most
CC       likely occupant of the site in vivo is potassium (PubMed:16784868,
CC       PubMed:11786021). Also activated by ammonium ion
CC       (PubMed:16784868). Ion binding induces a conformational change
CC       that may alter substrate affinity (Probable). {ECO:0000255|HAMAP-
CC       Rule:MF_01987, ECO:0000269|PubMed:11786021,
CC       ECO:0000269|PubMed:16784868, ECO:0000305|PubMed:11786021}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.213 mM for ATP {ECO:0000269|PubMed:16784868};
CC         KM=0.279 mM for D-ribose {ECO:0000269|PubMed:16784868};
CC         KM=1.41 mM for 2-deoxy-D-ribose {ECO:0000269|PubMed:16784868};
CC         KM=32 mM for D-arabinose {ECO:0000269|PubMed:16784868};
CC         KM=31.6 mM for D-xylose {ECO:0000269|PubMed:16784868};
CC         KM=8.2 mM for D-fructose {ECO:0000269|PubMed:16784868};
CC         KM=0.65 mM for ribose (at pH 6.2 in the presence of 0 mM
CC         inorganic phosphate) {ECO:0000269|PubMed:11563694};
CC         KM=0.43 mM for ribose (at pH 6.2 in the presence of 0.5 mM
CC         inorganic phosphate) {ECO:0000269|PubMed:11563694};
CC         KM=0.27 mM for ribose (at pH 6.2 in the presence of 1 mM
CC         inorganic phosphate) {ECO:0000269|PubMed:11563694};
CC         KM=0.23 mM for ribose (at pH 6.2 in the presence of 5 mM
CC         inorganic phosphate) {ECO:0000269|PubMed:11563694};
CC         KM=0.21 mM for ribose (at pH 6.2 in the presence of 20 mM
CC         inorganic phosphate) {ECO:0000269|PubMed:11563694};
CC         Vmax=122 umol/min/mg enzyme toward ATP
CC         {ECO:0000269|PubMed:16784868};
CC         Vmax=81 umol/min/mg enzyme toward D-ribose
CC         {ECO:0000269|PubMed:16784868};
CC         Vmax=25 umol/min/mg enzyme toward 2-deoxy-D-ribose
CC         {ECO:0000269|PubMed:16784868};
CC         Vmax=0.6 umol/min/mg enzyme toward D-arabinose
CC         {ECO:0000269|PubMed:16784868};
CC         Vmax=0.86 umol/min/mg enzyme toward D-xylose
CC         {ECO:0000269|PubMed:16784868};
CC         Vmax=0.226 umol/min/mg enzyme toward D-fructose
CC         {ECO:0000269|PubMed:16784868};
CC         Vmax=7.6 pmol/min/mg enzyme (at pH 6.2 in the presence of 0 mM
CC         inorganic phosphate) {ECO:0000269|PubMed:11563694};
CC         Vmax=32.0 pmol/min/mg enzyme (at pH 6.2 in the presence of 0.5
CC         mM inorganic phosphate) {ECO:0000269|PubMed:11563694};
CC         Vmax=59.6 pmol/min/mg enzyme (at pH 6.2 in the presence of 1 mM
CC         inorganic phosphate) {ECO:0000269|PubMed:11563694};
CC         Vmax=139.4 pmol/min/mg enzyme (at pH 6.2 in the presence of 5 mM
CC         inorganic phosphate) {ECO:0000269|PubMed:11563694};
CC         Vmax=172.4 pmol/min/mg enzyme (at pH 6.2 in the presence of 20
CC         mM inorganic phosphate) {ECO:0000269|PubMed:11563694};
CC       pH dependence:
CC         Optimum pH is 8-9. {ECO:0000269|PubMed:16784868};
CC       Temperature dependence:
CC         Optimum temperature is 30-50 degrees Celsius.
CC         {ECO:0000269|PubMed:16784868};
CC   -!- PATHWAY: Carbohydrate metabolism; D-ribose degradation; D-ribose
CC       5-phosphate from beta-D-ribopyranose: step 2/2.
CC       {ECO:0000255|HAMAP-Rule:MF_01987, ECO:0000305|PubMed:3011794}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_01987,
CC       ECO:0000269|PubMed:9385653}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_01987,
CC       ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the carbohydrate kinase PfkB family.
CC       Ribokinase subfamily. {ECO:0000255|HAMAP-Rule:MF_01987}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M13169; AAA51476.1; -; Genomic_DNA.
DR   EMBL; L10328; AAA62105.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76775.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77536.1; -; Genomic_DNA.
DR   PIR; A26305; KIECRB.
DR   RefSeq; NP_418208.1; NC_000913.3.
DR   RefSeq; WP_001300603.1; NZ_LN832404.1.
DR   PDB; 1GQT; X-ray; 2.34 A; A/B/C/D=1-309.
DR   PDB; 1RK2; X-ray; 2.25 A; A/B/C/D=1-309.
DR   PDB; 1RKA; X-ray; 2.30 A; A=1-309.
DR   PDB; 1RKD; X-ray; 1.84 A; A=1-309.
DR   PDB; 1RKS; X-ray; 2.40 A; A=1-309.
DR   PDBsum; 1GQT; -.
DR   PDBsum; 1RK2; -.
DR   PDBsum; 1RKA; -.
DR   PDBsum; 1RKD; -.
DR   PDBsum; 1RKS; -.
DR   ProteinModelPortal; P0A9J6; -.
DR   SMR; P0A9J6; -.
DR   BioGrid; 4259582; 11.
DR   DIP; DIP-36178N; -.
DR   IntAct; P0A9J6; 3.
DR   MINT; MINT-1321131; -.
DR   STRING; 511145.b3752; -.
DR   BindingDB; P0A9J6; -.
DR   ChEMBL; CHEMBL5093; -.
DR   DrugBank; DB01936; Ribose.
DR   DrugBank; DB04444; Tetrafluoroaluminate Ion.
DR   EPD; P0A9J6; -.
DR   PaxDb; P0A9J6; -.
DR   PRIDE; P0A9J6; -.
DR   EnsemblBacteria; AAC76775; AAC76775; b3752.
DR   EnsemblBacteria; BAE77536; BAE77536; BAE77536.
DR   GeneID; 948260; -.
DR   KEGG; ecj:JW3731; -.
DR   KEGG; eco:b3752; -.
DR   PATRIC; 32123003; VBIEscCol129921_3877.
DR   EchoBASE; EB0811; -.
DR   EcoGene; EG10818; rbsK.
DR   eggNOG; ENOG4108RVA; Bacteria.
DR   eggNOG; COG0524; LUCA.
DR   HOGENOM; HOG000235950; -.
DR   InParanoid; P0A9J6; -.
DR   KO; K00852; -.
DR   OMA; NADHVIS; -.
DR   PhylomeDB; P0A9J6; -.
DR   BioCyc; EcoCyc:RIBOKIN-MONOMER; -.
DR   BioCyc; MetaCyc:RIBOKIN-MONOMER; -.
DR   BRENDA; 2.7.1.15; 2026.
DR   UniPathway; UPA00916; UER00889.
DR   EvolutionaryTrace; P0A9J6; -.
DR   PRO; PR:P0A9J6; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004747; F:ribokinase activity; IDA:EcoCyc.
DR   GO; GO:0019303; P:D-ribose catabolic process; IMP:EcoCyc.
DR   CDD; cd01174; ribokinase; 1.
DR   Gene3D; 3.40.1190.20; -; 1.
DR   HAMAP; MF_01987; Ribokinase; 1.
DR   InterPro; IPR002173; Carboh/pur_kinase_PfkB_CS.
DR   InterPro; IPR011877; D_ribokin.
DR   InterPro; IPR011611; PfkB_dom.
DR   InterPro; IPR002139; Ribo/fructo_kinase.
DR   InterPro; IPR029056; Ribokinase-like.
DR   Pfam; PF00294; PfkB; 1.
DR   PRINTS; PR00990; RIBOKINASE.
DR   SUPFAM; SSF53613; SSF53613; 1.
DR   TIGRFAMs; TIGR02152; D_ribokin_bact; 1.
DR   PROSITE; PS00584; PFKB_KINASES_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Carbohydrate metabolism; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Potassium; Reference proteome;
KW   Transferase.
FT   CHAIN         1    309       Ribokinase.
FT                                /FTId=PRO_0000080097.
FT   NP_BIND     223    228       ATP. {ECO:0000255|HAMAP-Rule:MF_01987,
FT                                ECO:0000269|PubMed:10438599,
FT                                ECO:0000269|PubMed:11786021,
FT                                ECO:0000269|PubMed:9519409}.
FT   NP_BIND     254    255       ATP. {ECO:0000255|HAMAP-Rule:MF_01987,
FT                                ECO:0000269|PubMed:10438599,
FT                                ECO:0000269|PubMed:11786021}.
FT   REGION       14     16       Substrate binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_01987,
FT                                ECO:0000269|PubMed:10438599,
FT                                ECO:0000269|PubMed:11786021,
FT                                ECO:0000269|PubMed:9519409}.
FT   REGION       42     46       Substrate binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_01987,
FT                                ECO:0000269|PubMed:10438599,
FT                                ECO:0000269|PubMed:11786021,
FT                                ECO:0000269|PubMed:9519409}.
FT   ACT_SITE    255    255       Proton acceptor. {ECO:0000255|HAMAP-
FT                                Rule:MF_01987,
FT                                ECO:0000305|PubMed:11786021}.
FT   METAL       249    249       Potassium. {ECO:0000255|HAMAP-
FT                                Rule:MF_01987,
FT                                ECO:0000305|PubMed:11786021}.
FT   METAL       251    251       Potassium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_01987,
FT                                ECO:0000305|PubMed:11786021}.
FT   METAL       285    285       Potassium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_01987,
FT                                ECO:0000305|PubMed:11786021}.
FT   METAL       288    288       Potassium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_01987,
FT                                ECO:0000305|PubMed:11786021}.
FT   METAL       290    290       Potassium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_01987,
FT                                ECO:0000305|PubMed:11786021}.
FT   METAL       294    294       Potassium. {ECO:0000255|HAMAP-
FT                                Rule:MF_01987,
FT                                ECO:0000305|PubMed:11786021}.
FT   BINDING     143    143       Substrate. {ECO:0000255|HAMAP-
FT                                Rule:MF_01987,
FT                                ECO:0000269|PubMed:10438599,
FT                                ECO:0000269|PubMed:11786021,
FT                                ECO:0000269|PubMed:9519409}.
FT   BINDING     187    187       ATP. {ECO:0000255|HAMAP-Rule:MF_01987,
FT                                ECO:0000269|PubMed:10438599,
FT                                ECO:0000269|PubMed:11786021,
FT                                ECO:0000269|PubMed:9519409}.
FT   BINDING     255    255       Substrate. {ECO:0000255|HAMAP-
FT                                Rule:MF_01987,
FT                                ECO:0000269|PubMed:10438599,
FT                                ECO:0000269|PubMed:11786021,
FT                                ECO:0000269|PubMed:9519409}.
FT   BINDING     279    279       ATP. {ECO:0000255|HAMAP-Rule:MF_01987,
FT                                ECO:0000269|PubMed:10438599,
FT                                ECO:0000269|PubMed:11786021,
FT                                ECO:0000269|PubMed:9519409}.
FT   STRAND        6     10       {ECO:0000244|PDB:1RKD}.
FT   STRAND       14     20       {ECO:0000244|PDB:1RKD}.
FT   STRAND       30     32       {ECO:0000244|PDB:1RK2}.
FT   STRAND       36     41       {ECO:0000244|PDB:1RKD}.
FT   HELIX        43     54       {ECO:0000244|PDB:1RKD}.
FT   STRAND       57     67       {ECO:0000244|PDB:1RKD}.
FT   HELIX        70     78       {ECO:0000244|PDB:1RKD}.
FT   TURN         79     81       {ECO:0000244|PDB:1RKD}.
FT   STRAND       87     90       {ECO:0000244|PDB:1RKD}.
FT   STRAND       96    102       {ECO:0000244|PDB:1RKD}.
FT   STRAND      108    113       {ECO:0000244|PDB:1RKD}.
FT   HELIX       115    119       {ECO:0000244|PDB:1RKD}.
FT   HELIX       122    126       {ECO:0000244|PDB:1RKD}.
FT   HELIX       129    134       {ECO:0000244|PDB:1RKD}.
FT   STRAND      136    140       {ECO:0000244|PDB:1RKD}.
FT   STRAND      142    144       {ECO:0000244|PDB:1RKD}.
FT   HELIX       146    158       {ECO:0000244|PDB:1RKD}.
FT   STRAND      162    165       {ECO:0000244|PDB:1RKD}.
FT   HELIX       175    178       {ECO:0000244|PDB:1RKD}.
FT   STRAND      182    184       {ECO:0000244|PDB:1RKD}.
FT   HELIX       188    195       {ECO:0000244|PDB:1RKD}.
FT   HELIX       202    214       {ECO:0000244|PDB:1RKD}.
FT   STRAND      218    223       {ECO:0000244|PDB:1RKD}.
FT   HELIX       225    227       {ECO:0000244|PDB:1RKD}.
FT   STRAND      229    233       {ECO:0000244|PDB:1RKD}.
FT   STRAND      236    240       {ECO:0000244|PDB:1RKD}.
FT   HELIX       253    266       {ECO:0000244|PDB:1RKD}.
FT   HELIX       271    286       {ECO:0000244|PDB:1RKD}.
FT   STRAND      288    291       {ECO:0000244|PDB:1RKD}.
FT   HELIX       292    294       {ECO:0000244|PDB:1RKD}.
FT   HELIX       298    306       {ECO:0000244|PDB:1RKD}.
SQ   SEQUENCE   309 AA;  32291 MW;  753729B41E64060E CRC64;
     MQNAGSLVVL GSINADHILN LQSFPTPGET VTGNHYQVAF GGKGANQAVA AGRSGANIAF
     IACTGDDSIG ESVRQQLATD NIDITPVSVI KGESTGVALI FVNGEGENVI GIHAGANAAL
     SPALVEAQRE RIANASALLM QLESPLESVM AAAKIAHQNK TIVALNPAPA RELPDELLAL
     VDIITPNETE AEKLTGIRVE NDEDAAKAAQ VLHEKGIRTV LITLGSRGVW ASVNGEGQRV
     PGFRVQAVDT IAAGDTFNGA LITALLEEKP LPEAIRFAHA AAAIAVTRKG AQPSVPWREE
     IDAFLDRQR
//
